Cerapedics

Private

Westminster, ColoradoHealthcare & Life Scienceshttps://www.cerapedics.com/

Last Round

VC Round

Mar 23, 2022

Total Funding Raised

$106.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cerapedics is an orthobiologics company that develops and commercializes proprietary synthetic small peptide (P-15) technology platforms for bone repair and orthopedic procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthobiologicsbone graft substitutespinal fusioni-FACTORP-15 peptidesynthetic bone graftbone regenerationdrug-device combinationACDFTLIFClass III medical devicePMAFDA premarket approvalbone repairanterior cervical discectomy and fusiontransforaminal lumbar interbody fusionPearlMatrix

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cerapedics Comps

Public and private peers based on sector, stage, and business model.

Cerapedics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cerapedics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Mar 23, 2022
VC Round	Jul 13, 2018
Debt	Apr 19, 2017
Series D	Sep 29, 2016
Debt	Apr 7, 2015
Debt	Apr 14, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Valeska Schroeder

Chief Executive Officer, Chairman Of The Board, Board Member

Executive Team

Mani Gopal

Chief Operating Officer

Executive Team

Cerapedics Investors

Notable investors and investment history

Cerapedics investors
Investor	Rounds
KCK MedTech	VC Round
GE Capital	Debt
OrbiMed	Series B, Series C, Series A
MedImmune Ventures	Series C
Oxford Finance	Debt
NGN Capital	Series C, Series B
Revelation Partners	Series D

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 1, 2026
Next-generation product evaluated in pivotal ASPIRE FDA IDE study.
Jan 1, 2026
Next-generation product granted Breakthrough Device Designation by the FDA.

View all signals

Cerapedics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cerapedics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cerapedics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWestminster, Colorado

Employee Range191

Year Founded2001

Last FundingMar 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.